Literature DB >> 25429852

Phenotype variations of retinal dystrophies caused by mutations in the RLBP1 gene.

Stephanie Hipp1, Gergely Zobor2, Nicola Glöckle3, Julia Mohr3, Susanne Kohl4, Eberhart Zrenner2,5, Nicole Weisschuh4, Ditta Zobor2.   

Abstract

PURPOSE: Mutations in the RLBP1 gene encoding the cellular retinaldehyde-binding protein (CRALBP) cause autosomal recessive progressive retinopathy, such as retinitis punctata albescens (RPA), Bothnia-type dystrophy (BD), Newfoundland rod-cone dystrophy (NFRCD), retinitis pigmentosa (RP) and fundus albipunctatus (FA). We present the clinical heterogeneity and genetic findings of seven patients from five families with RLBP1 mutations, including three novel mutations.
METHODS: Seven patients underwent complete ophthalmological examination including psychophysical tests (visual acuity, colour vision, visual field, dark adaptation) and electrophysiology (Ganzfeld and multifocal ERG). Additionally, fundus photography, autofluorescence (FAF) and spectral domain optical coherence tomography (OCT) recordings were performed. Genomic DNA was analysed by high-throughput sequencing for all RP-related genes in a diagnostic set-up.
RESULTS: The patients presented with variable phenotypes, including RPA, BD, RP and a mild form of NFRCD. No detectable or severely depressed responses in electrophysiological examinations were seen in all cases. Visual field constriction was variable among individuals. Severely reduced visual acuity was only observed in the patient presenting with BD. The other patients retained mild to moderate reduction of visual function. Despite the morphological differences, central retinal thinning - as a common feature - could be observed.
CONCLUSIONS: The fact that different mutations in RLBP1 are correlated with quite different morphological and functional characteristics outlines the complexity of the protein. Identifying new mutations and comparing the different phenotypes may help to better understand the function of the protein and the consequences in pathological changes that involve RPE and choroid.
© 2014 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  RLBP1 mutations; genotype-phenotype correlations; retinitis pigmentosa; retinitis punctata albescens

Mesh:

Substances:

Year:  2014        PMID: 25429852     DOI: 10.1111/aos.12573

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  13 in total

1.  Joint Analysis of Nuclear and Mitochondrial Variants in Age-Related Macular Degeneration Identifies Novel Loci TRPM1 and ABHD2/RLBP1.

Authors:  Patrice J Persad; Iris M Heid; Daniel E Weeks; Paul N Baird; Eiko K de Jong; Jonathan L Haines; Margaret A Pericak-Vance; William K Scott
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-08-01       Impact factor: 4.799

2.  A novel RLBP1 gene geographical area-related mutation present in a young patient with retinitis punctata albescens.

Authors:  Concetta Scimone; Luigi Donato; Teresa Esposito; Carmela Rinaldi; Rosalia D'Angelo; Antonina Sidoti
Journal:  Hum Genomics       Date:  2017-08-01       Impact factor: 4.639

3.  Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci.

Authors:  Thomas W Winkler; Caroline Brandl; Felix Grassmann; Mathias Gorski; Klaus Stark; Julika Loss; Bernhard H F Weber; Iris M Heid
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

4.  Proteomic analysis of the human retina reveals region-specific susceptibilities to metabolic- and oxidative stress-related diseases.

Authors:  Gabriel Velez; Daniel A Machlab; Peter H Tang; Yang Sun; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

5.  Clinical heterogeneity in retinitis pigmentosa caused by variants in RP1 and RLBP1 in five extended consanguineous pedigrees.

Authors:  Muawyah Al-Bdour; Svenja Pauleck; Zain Dardas; Raghda Barham; Dema Ali; Sami Amr; Lina Mustafa; Mohammed Abu-Ameerh; Ranad Maswadi; Belal Azab; Abdalla Awidi
Journal:  Mol Vis       Date:  2020-06-19       Impact factor: 2.367

6.  A multimodal study and management of retinitis punctata albescens.

Authors:  Glenda Espinosa-Barberi; José Francisco Galván González; David Viera Peláez
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

7.  Nanomedicine-based Curcumin Approach Improved ROS Damage in Best Dystrophy-specific Induced Pluripotent Stem Cells.

Authors:  Tai-Chi Lin; Yi-Ying Lin; Chih-Chen Hsu; Yi-Ping Yang; Chang-Hao Yang; De-Kuang Hwang; Chien-Ying Wang; Yung-Yang Liu; Wen-Liang Lo; Shih-Hwa Chiou; Chi-Hsien Peng; Shih-Jen Chen; Yuh-Lih Chang
Journal:  Cell Transplant       Date:  2019-07-17       Impact factor: 4.064

Review 8.  The electroretinogram in the genomics era: outer retinal disorders.

Authors:  Elisa E Cornish; Anagha Vaze; Robyn V Jamieson; John R Grigg
Journal:  Eye (Lond)       Date:  2021-07-07       Impact factor: 4.456

9.  Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing.

Authors:  Nicole Weisschuh; Anja K Mayer; Tim M Strom; Susanne Kohl; Nicola Glöckle; Max Schubach; Sten Andreasson; Antje Bernd; David G Birch; Christian P Hamel; John R Heckenlively; Samuel G Jacobson; Christina Kamme; Ulrich Kellner; Erdmute Kunstmann; Pietro Maffei; Charlotte M Reiff; Klaus Rohrschneider; Thomas Rosenberg; Günther Rudolph; Rita Vámos; Balázs Varsányi; Richard G Weleber; Bernd Wissinger
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

10.  Effects of deficiency in the RLBP1-encoded visual cycle protein CRALBP on visual dysfunction in humans and mice.

Authors:  Jose Ronaldo Lima de Carvalho; Hye Jin Kim; Keiko Ueda; Jin Zhao; Aaron P Owji; Tingting Yang; Stephen H Tsang; Janet R Sparrow
Journal:  J Biol Chem       Date:  2020-03-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.